nodes	percent_of_prediction	percent_of_DWPC	metapath
Everolimus—CYP3A4—Budesonide—ulcerative colitis	0.1	0.257	CbGbCtD
Everolimus—CYP3A4—Methylprednisolone—ulcerative colitis	0.0447	0.115	CbGbCtD
Everolimus—CYP3A4—Nicotine—ulcerative colitis	0.0436	0.112	CbGbCtD
Everolimus—CYP3A4—Cholecalciferol—ulcerative colitis	0.0391	0.1	CbGbCtD
Everolimus—CYP3A4—Triamcinolone—ulcerative colitis	0.0339	0.0868	CbGbCtD
Everolimus—CYP3A4—Betamethasone—ulcerative colitis	0.0291	0.0745	CbGbCtD
Everolimus—CYP3A4—Prednisolone—ulcerative colitis	0.0287	0.0735	CbGbCtD
Everolimus—CYP3A4—Hydrocortisone—ulcerative colitis	0.0272	0.0697	CbGbCtD
Everolimus—CYP3A4—Prednisone—ulcerative colitis	0.0271	0.0694	CbGbCtD
Everolimus—CYP3A4—Dexamethasone—ulcerative colitis	0.0169	0.0433	CbGbCtD
Everolimus—MTOR—epithelium—ulcerative colitis	0.00329	0.123	CbGeAlD
Everolimus—MTOR—smooth muscle tissue—ulcerative colitis	0.00317	0.119	CbGeAlD
Everolimus—FKBP1A—epithelium—ulcerative colitis	0.00296	0.111	CbGeAlD
Everolimus—FKBP1A—smooth muscle tissue—ulcerative colitis	0.00285	0.107	CbGeAlD
Everolimus—MTOR—lymphoid tissue—ulcerative colitis	0.00253	0.095	CbGeAlD
Everolimus—MTOR—digestive system—ulcerative colitis	0.0025	0.0939	CbGeAlD
Everolimus—FKBP1A—lymphoid tissue—ulcerative colitis	0.00228	0.0855	CbGeAlD
Everolimus—FKBP1A—digestive system—ulcerative colitis	0.00225	0.0844	CbGeAlD
Everolimus—MTOR—liver—ulcerative colitis	0.00186	0.0699	CbGeAlD
Everolimus—FKBP1A—liver—ulcerative colitis	0.00168	0.0629	CbGeAlD
Everolimus—Temsirolimus—ABCB1—ulcerative colitis	0.00126	0.272	CrCbGaD
Everolimus—Tacrolimus—ALB—ulcerative colitis	0.00116	0.25	CrCbGaD
Everolimus—Sirolimus—ABCB1—ulcerative colitis	0.00111	0.239	CrCbGaD
Everolimus—Tacrolimus—ABCB1—ulcerative colitis	0.00111	0.239	CrCbGaD
Everolimus—CYP3A4—digestive system—ulcerative colitis	0.000735	0.0276	CbGeAlD
Everolimus—CYP3A4—liver—ulcerative colitis	0.000548	0.0206	CbGeAlD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	0.000316	0.00176	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—ADCY5—ulcerative colitis	0.000314	0.00175	CbGpPWpGaD
Everolimus—FKBP1A—Spinal Cord Injury—TNF—ulcerative colitis	0.000313	0.00174	CbGpPWpGaD
Everolimus—FKBP1A—Disease—LTF—ulcerative colitis	0.000312	0.00174	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—CALM3—ulcerative colitis	0.000302	0.00168	CbGpPWpGaD
Everolimus—MTOR—CXCR4-mediated signaling events—MMP9—ulcerative colitis	0.0003	0.00167	CbGpPWpGaD
Everolimus—MTOR—VEGFA-VEGFR2 Pathway—JAK2—ulcerative colitis	0.0003	0.00167	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—IFNG—ulcerative colitis	0.000299	0.00166	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—RIPK2—ulcerative colitis	0.000297	0.00166	CbGpPWpGaD
Everolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—ulcerative colitis	0.000297	0.00166	CbGpPWpGaD
Everolimus—MTOR—TSLP Signaling Pathway—IL6—ulcerative colitis	0.000297	0.00165	CbGpPWpGaD
Everolimus—MTOR—Regulation of Telomerase—TGFB1—ulcerative colitis	0.000293	0.00163	CbGpPWpGaD
Everolimus—MTOR—Leptin signaling pathway—STAT3—ulcerative colitis	0.000292	0.00163	CbGpPWpGaD
Everolimus—MTOR—ErbB Signaling Pathway—TP53—ulcerative colitis	0.00029	0.00162	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—ADCY5—ulcerative colitis	0.000285	0.00159	CbGpPWpGaD
Everolimus—MTOR—Signaling by VEGF—JAK2—ulcerative colitis	0.000283	0.00158	CbGpPWpGaD
Everolimus—MTOR—Signaling by Insulin receptor—JAK2—ulcerative colitis	0.000281	0.00157	CbGpPWpGaD
Everolimus—MTOR—Immune System—HERC2—ulcerative colitis	0.00028	0.00156	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—CXCL8—ulcerative colitis	0.000278	0.00155	CbGpPWpGaD
Everolimus—FKBP1A—Spinal Cord Injury—TP53—ulcerative colitis	0.000276	0.00154	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	0.000274	0.00153	CbGpPWpGaD
Everolimus—MTOR—CXCR4-mediated signaling events—STAT3—ulcerative colitis	0.000267	0.00149	CbGpPWpGaD
Everolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—STAT3—ulcerative colitis	0.000267	0.00149	CbGpPWpGaD
Everolimus—MTOR—Immune System—MASP2—ulcerative colitis	0.000267	0.00149	CbGpPWpGaD
Everolimus—MTOR—Immune System—ICOSLG—ulcerative colitis	0.000267	0.00149	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—IL1B—ulcerative colitis	0.000266	0.00148	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—CDH1—ulcerative colitis	0.00026	0.00145	CbGpPWpGaD
Everolimus—FKBP1A—Spinal Cord Injury—IL6—ulcerative colitis	0.000253	0.00141	CbGpPWpGaD
Everolimus—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000251	0.0014	CbGpPWpGaD
Everolimus—MTOR—Oncostatin M Signaling Pathway—TP53—ulcerative colitis	0.00025	0.00139	CbGpPWpGaD
Everolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—ulcerative colitis	0.000248	0.00138	CbGpPWpGaD
Everolimus—MTOR—Disease—CHP1—ulcerative colitis	0.000246	0.00137	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—SEL1L—ulcerative colitis	0.000244	0.00136	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—JAK2—ulcerative colitis	0.00024	0.00134	CbGpPWpGaD
Everolimus—MTOR—AMPK Signaling—TP53—ulcerative colitis	0.000239	0.00133	CbGpPWpGaD
Everolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000238	0.00133	CbGpPWpGaD
Everolimus—MTOR—Immune System—TNFRSF14—ulcerative colitis	0.000238	0.00132	CbGpPWpGaD
Everolimus—MTOR—Immune System—DEFA5—ulcerative colitis	0.000238	0.00132	CbGpPWpGaD
Everolimus—MTOR—BDNF signaling pathway—JAK2—ulcerative colitis	0.000236	0.00132	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—ITGAL—ulcerative colitis	0.000233	0.0013	CbGpPWpGaD
Everolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TNF—ulcerative colitis	0.000231	0.00129	CbGpPWpGaD
Everolimus—MTOR—Immune System—ARPC2—ulcerative colitis	0.00023	0.00128	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling of activated FGFR—JAK2—ulcerative colitis	0.00023	0.00128	CbGpPWpGaD
Everolimus—MTOR—BDNF signaling pathway—RELA—ulcerative colitis	0.000229	0.00128	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	0.000228	0.00127	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB4—JAK2—ulcerative colitis	0.000226	0.00126	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL1R2—ulcerative colitis	0.000224	0.00125	CbGpPWpGaD
Everolimus—MTOR—ErbB1 downstream signaling—STAT3—ulcerative colitis	0.000223	0.00124	CbGpPWpGaD
Everolimus—FKBP1A—Disease—SLC11A1—ulcerative colitis	0.000222	0.00124	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—CCR6—ulcerative colitis	0.000221	0.00123	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—ADCY5—ulcerative colitis	0.000219	0.00122	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—JAK2—ulcerative colitis	0.000216	0.0012	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—JAK2—ulcerative colitis	0.000215	0.0012	CbGpPWpGaD
Everolimus—MTOR—EGF/EGFR Signaling Pathway—JAK2—ulcerative colitis	0.000215	0.0012	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—JAK2—ulcerative colitis	0.000214	0.00119	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—JAK2—ulcerative colitis	0.000213	0.00119	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	0.000213	0.00119	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—FCGR2A—ulcerative colitis	0.00021	0.00117	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—TGFB1—ulcerative colitis	0.000207	0.00115	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—RELA—ulcerative colitis	0.000203	0.00113	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CXCR1—ulcerative colitis	0.000201	0.00112	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—JAK2—ulcerative colitis	0.0002	0.00112	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—JAK2—ulcerative colitis	0.0002	0.00112	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—JAK2—ulcerative colitis	0.0002	0.00112	CbGpPWpGaD
Everolimus—FKBP1A—Disease—MAML2—ulcerative colitis	0.0002	0.00111	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—JAK2—ulcerative colitis	0.000199	0.00111	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—MMP9—ulcerative colitis	0.000198	0.00111	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—JAK2—ulcerative colitis	0.000197	0.0011	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—JAK2—ulcerative colitis	0.000196	0.00109	CbGpPWpGaD
Everolimus—MTOR—Disease—SEL1L—ulcerative colitis	0.000196	0.00109	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—RELA—ulcerative colitis	0.000194	0.00108	CbGpPWpGaD
Everolimus—MTOR—Immune System—CARD9—ulcerative colitis	0.000194	0.00108	CbGpPWpGaD
Everolimus—MTOR—BDNF signaling pathway—NFKB1—ulcerative colitis	0.000193	0.00108	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL7R—ulcerative colitis	0.00019	0.00106	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	0.000188	0.00105	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—NFKB1—ulcerative colitis	0.000186	0.00104	CbGpPWpGaD
Everolimus—MTOR—IRS-mediated signalling—IL6—ulcerative colitis	0.000185	0.00103	CbGpPWpGaD
Everolimus—MTOR—IRS-related events—IL6—ulcerative colitis	0.00018	0.001	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—RELA—ulcerative colitis	0.00018	0.001	CbGpPWpGaD
Everolimus—MTOR—IRS-related events triggered by IGF1R—IL6—ulcerative colitis	0.000178	0.000992	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—JAK2—ulcerative colitis	0.000178	0.000989	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—STAT3—ulcerative colitis	0.000176	0.000983	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CCL20—ulcerative colitis	0.000176	0.000981	CbGpPWpGaD
Everolimus—MTOR—Disease—LTF—ulcerative colitis	0.000176	0.000978	CbGpPWpGaD
Everolimus—MTOR—BDNF signaling pathway—STAT3—ulcerative colitis	0.000174	0.000966	CbGpPWpGaD
Everolimus—MTOR—Insulin receptor signalling cascade—IL6—ulcerative colitis	0.000173	0.000966	CbGpPWpGaD
Everolimus—MTOR—IGF1R signaling cascade—IL6—ulcerative colitis	0.000173	0.000966	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—CALM3—ulcerative colitis	0.000172	0.000959	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—ulcerative colitis	0.000171	0.000955	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—TP53—ulcerative colitis	0.00017	0.000949	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—RIPK2—ulcerative colitis	0.00017	0.000945	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—GNA12—ulcerative colitis	0.000166	0.000923	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CALM3—ulcerative colitis	0.000165	0.000921	CbGpPWpGaD
Everolimus—FKBP1A—Disease—CALM3—ulcerative colitis	0.000165	0.000917	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—NFKB1—ulcerative colitis	0.000164	0.000912	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—RIPK2—ulcerative colitis	0.000163	0.000907	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CTLA4—ulcerative colitis	0.000161	0.000894	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—STAT3—ulcerative colitis	0.000159	0.000884	CbGpPWpGaD
Everolimus—MTOR—EGF/EGFR Signaling Pathway—STAT3—ulcerative colitis	0.000158	0.000879	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CXCR2—ulcerative colitis	0.000157	0.000875	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—IL6—ulcerative colitis	0.000156	0.000869	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—NOD2—ulcerative colitis	0.000154	0.000856	CbGpPWpGaD
Everolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—ulcerative colitis	0.000154	0.000856	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CD79A—ulcerative colitis	0.000153	0.000853	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—CD14—ulcerative colitis	0.000153	0.000851	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—NFKB1—ulcerative colitis	0.000151	0.000844	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CCR6—ulcerative colitis	0.000148	0.000822	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—STAT3—ulcerative colitis	0.000147	0.000819	CbGpPWpGaD
Everolimus—Shock—Prednisolone—ulcerative colitis	0.000145	0.000365	CcSEcCtD
Everolimus—Cough—Triamcinolone—ulcerative colitis	0.000145	0.000364	CcSEcCtD
Everolimus—MTOR—Signaling by VEGF—IL6—ulcerative colitis	0.000145	0.000808	CbGpPWpGaD
Everolimus—Oedema—Hydrocortisone—ulcerative colitis	0.000144	0.000362	CcSEcCtD
Everolimus—Convulsion—Triamcinolone—ulcerative colitis	0.000144	0.000362	CcSEcCtD
Everolimus—Tachycardia—Prednisolone—ulcerative colitis	0.000144	0.000362	CcSEcCtD
Everolimus—MTOR—Signaling by Insulin receptor—IL6—ulcerative colitis	0.000144	0.000802	CbGpPWpGaD
Everolimus—Convulsion—Methylprednisolone—ulcerative colitis	0.000144	0.000361	CcSEcCtD
Everolimus—MTOR—Signaling by PDGF—STAT3—ulcerative colitis	0.000144	0.000801	CbGpPWpGaD
Everolimus—Hypertension—Triamcinolone—ulcerative colitis	0.000144	0.00036	CcSEcCtD
Everolimus—Pruritus—Mesalazine—ulcerative colitis	0.000144	0.00036	CcSEcCtD
Everolimus—Hypertension—Methylprednisolone—ulcerative colitis	0.000143	0.00036	CcSEcCtD
Everolimus—Infection—Hydrocortisone—ulcerative colitis	0.000143	0.00036	CcSEcCtD
Everolimus—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000143	0.000358	CcSEcCtD
Everolimus—Shock—Hydrocortisone—ulcerative colitis	0.000142	0.000356	CcSEcCtD
Everolimus—Myalgia—Triamcinolone—ulcerative colitis	0.000142	0.000355	CcSEcCtD
Everolimus—Vomiting—Azathioprine—ulcerative colitis	0.000142	0.000355	CcSEcCtD
Everolimus—MTOR—Adaptive Immune System—VCAM1—ulcerative colitis	0.000142	0.000789	CbGpPWpGaD
Everolimus—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000142	0.000355	CcSEcCtD
Everolimus—Myalgia—Methylprednisolone—ulcerative colitis	0.000141	0.000355	CcSEcCtD
Everolimus—Arthralgia—Methylprednisolone—ulcerative colitis	0.000141	0.000355	CcSEcCtD
Everolimus—MTOR—Immune System—ITGAL—ulcerative colitis	0.000141	0.000788	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—HLA-DQA1—ulcerative colitis	0.000141	0.000787	CbGpPWpGaD
Everolimus—Eye disorder—Prednisone—ulcerative colitis	0.000141	0.000354	CcSEcCtD
Everolimus—Anxiety—Methylprednisolone—ulcerative colitis	0.000141	0.000353	CcSEcCtD
Everolimus—MTOR—Cellular responses to stress—RELA—ulcerative colitis	0.000141	0.000785	CbGpPWpGaD
Everolimus—Tachycardia—Hydrocortisone—ulcerative colitis	0.000141	0.000353	CcSEcCtD
Everolimus—Rash—Azathioprine—ulcerative colitis	0.000141	0.000352	CcSEcCtD
Everolimus—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000141	0.000352	CcSEcCtD
Everolimus—Dermatitis—Azathioprine—ulcerative colitis	0.00014	0.000352	CcSEcCtD
Everolimus—Flushing—Prednisone—ulcerative colitis	0.00014	0.000352	CcSEcCtD
Everolimus—Skin disorder—Hydrocortisone—ulcerative colitis	0.00014	0.000351	CcSEcCtD
Everolimus—Ill-defined disorder—Betamethasone—ulcerative colitis	0.00014	0.000351	CcSEcCtD
Everolimus—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.00014	0.000351	CcSEcCtD
Everolimus—Discomfort—Triamcinolone—ulcerative colitis	0.00014	0.000351	CcSEcCtD
Everolimus—FKBP1A—Signaling Pathways—MAML2—ulcerative colitis	0.00014	0.00078	CbGpPWpGaD
Everolimus—Discomfort—Methylprednisolone—ulcerative colitis	0.00014	0.00035	CcSEcCtD
Everolimus—Headache—Azathioprine—ulcerative colitis	0.00014	0.00035	CcSEcCtD
Everolimus—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.00014	0.00035	CcSEcCtD
Everolimus—Diarrhoea—Mesalazine—ulcerative colitis	0.000139	0.000348	CcSEcCtD
Everolimus—Dry mouth—Triamcinolone—ulcerative colitis	0.000139	0.000348	CcSEcCtD
Everolimus—Angioedema—Dexamethasone—ulcerative colitis	0.000138	0.000346	CcSEcCtD
Everolimus—Angioedema—Betamethasone—ulcerative colitis	0.000138	0.000346	CcSEcCtD
Everolimus—Anorexia—Hydrocortisone—ulcerative colitis	0.000138	0.000345	CcSEcCtD
Everolimus—Angiopathy—Prednisone—ulcerative colitis	0.000137	0.000344	CcSEcCtD
Everolimus—MTOR—Signaling Pathways—SEL1L—ulcerative colitis	0.000137	0.000763	CbGpPWpGaD
Everolimus—Immune system disorder—Prednisone—ulcerative colitis	0.000137	0.000342	CcSEcCtD
Everolimus—MTOR—Signaling by NGF—JAK2—ulcerative colitis	0.000137	0.00076	CbGpPWpGaD
Everolimus—Malaise—Betamethasone—ulcerative colitis	0.000136	0.000342	CcSEcCtD
Everolimus—Malaise—Dexamethasone—ulcerative colitis	0.000136	0.000342	CcSEcCtD
Everolimus—Oedema—Triamcinolone—ulcerative colitis	0.000136	0.000341	CcSEcCtD
Everolimus—Syncope—Dexamethasone—ulcerative colitis	0.000136	0.00034	CcSEcCtD
Everolimus—Syncope—Betamethasone—ulcerative colitis	0.000136	0.00034	CcSEcCtD
Everolimus—Infection—Triamcinolone—ulcerative colitis	0.000135	0.000339	CcSEcCtD
Everolimus—Hypotension—Hydrocortisone—ulcerative colitis	0.000135	0.000338	CcSEcCtD
Everolimus—Infection—Methylprednisolone—ulcerative colitis	0.000135	0.000338	CcSEcCtD
Everolimus—MTOR—Immune System—IRF5—ulcerative colitis	0.000134	0.000749	CbGpPWpGaD
Everolimus—Dizziness—Mesalazine—ulcerative colitis	0.000134	0.000337	CcSEcCtD
Everolimus—Shock—Triamcinolone—ulcerative colitis	0.000134	0.000335	CcSEcCtD
Everolimus—Insomnia—Prednisolone—ulcerative colitis	0.000134	0.000335	CcSEcCtD
Everolimus—Alopecia—Prednisone—ulcerative colitis	0.000134	0.000335	CcSEcCtD
Everolimus—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	0.000134	0.000744	CbGpPWpGaD
Everolimus—Shock—Methylprednisolone—ulcerative colitis	0.000133	0.000334	CcSEcCtD
Everolimus—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000133	0.000333	CcSEcCtD
Everolimus—MTOR—Cellular responses to stress—CXCL8—ulcerative colitis	0.000133	0.00074	CbGpPWpGaD
Everolimus—Loss of consciousness—Betamethasone—ulcerative colitis	0.000133	0.000333	CcSEcCtD
Everolimus—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000133	0.000333	CcSEcCtD
Everolimus—Paraesthesia—Prednisolone—ulcerative colitis	0.000133	0.000333	CcSEcCtD
Everolimus—Tachycardia—Triamcinolone—ulcerative colitis	0.000133	0.000333	CcSEcCtD
Everolimus—Mental disorder—Prednisone—ulcerative colitis	0.000132	0.000332	CcSEcCtD
Everolimus—Nausea—Azathioprine—ulcerative colitis	0.000132	0.000332	CcSEcCtD
Everolimus—Tachycardia—Methylprednisolone—ulcerative colitis	0.000132	0.000332	CcSEcCtD
Everolimus—MTOR—Signaling by NGF—RELA—ulcerative colitis	0.000132	0.000736	CbGpPWpGaD
Everolimus—Skin disorder—Methylprednisolone—ulcerative colitis	0.000132	0.00033	CcSEcCtD
Everolimus—Erythema—Prednisone—ulcerative colitis	0.000132	0.00033	CcSEcCtD
Everolimus—Malnutrition—Prednisone—ulcerative colitis	0.000132	0.00033	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000132	0.00033	CcSEcCtD
Everolimus—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000131	0.000329	CcSEcCtD
Everolimus—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000131	0.000329	CcSEcCtD
Everolimus—Convulsion—Dexamethasone—ulcerative colitis	0.000131	0.000328	CcSEcCtD
Everolimus—Convulsion—Betamethasone—ulcerative colitis	0.000131	0.000328	CcSEcCtD
Everolimus—Insomnia—Hydrocortisone—ulcerative colitis	0.000131	0.000327	CcSEcCtD
Everolimus—Hypertension—Dexamethasone—ulcerative colitis	0.00013	0.000327	CcSEcCtD
Everolimus—Hypertension—Betamethasone—ulcerative colitis	0.00013	0.000327	CcSEcCtD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—STAT3—ulcerative colitis	0.00013	0.000726	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—PTGER4—ulcerative colitis	0.00013	0.000724	CbGpPWpGaD
Everolimus—Paraesthesia—Hydrocortisone—ulcerative colitis	0.00013	0.000325	CcSEcCtD
Everolimus—Vomiting—Mesalazine—ulcerative colitis	0.000129	0.000324	CcSEcCtD
Everolimus—Myalgia—Dexamethasone—ulcerative colitis	0.000129	0.000323	CcSEcCtD
Everolimus—Myalgia—Betamethasone—ulcerative colitis	0.000129	0.000323	CcSEcCtD
Everolimus—MTOR—Immune System—IRF8—ulcerative colitis	0.000128	0.000715	CbGpPWpGaD
Everolimus—MTOR—Immune System—CCR6—ulcerative colitis	0.000128	0.000715	CbGpPWpGaD
Everolimus—Anxiety—Betamethasone—ulcerative colitis	0.000128	0.000321	CcSEcCtD
Everolimus—Anxiety—Dexamethasone—ulcerative colitis	0.000128	0.000321	CcSEcCtD
Everolimus—Rash—Mesalazine—ulcerative colitis	0.000128	0.000321	CcSEcCtD
Everolimus—Dermatitis—Mesalazine—ulcerative colitis	0.000128	0.000321	CcSEcCtD
Everolimus—MTOR—Integrated Breast Cancer Pathway—TP53—ulcerative colitis	0.000127	0.00071	CbGpPWpGaD
Everolimus—Headache—Mesalazine—ulcerative colitis	0.000127	0.000319	CcSEcCtD
Everolimus—Discomfort—Betamethasone—ulcerative colitis	0.000127	0.000319	CcSEcCtD
Everolimus—Discomfort—Dexamethasone—ulcerative colitis	0.000127	0.000319	CcSEcCtD
Everolimus—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000127	0.000319	CcSEcCtD
Everolimus—Hypotension—Methylprednisolone—ulcerative colitis	0.000127	0.000318	CcSEcCtD
Everolimus—Pain—Prednisolone—ulcerative colitis	0.000126	0.000317	CcSEcCtD
Everolimus—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000125	0.000315	CcSEcCtD
Everolimus—MTOR—Disease—SLC11A1—ulcerative colitis	0.000125	0.000697	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—ADCY5—ulcerative colitis	0.000125	0.000696	CbGpPWpGaD
Everolimus—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000125	0.000312	CcSEcCtD
Everolimus—Fatigue—Hydrocortisone—ulcerative colitis	0.000124	0.000312	CcSEcCtD
Everolimus—Vision blurred—Prednisone—ulcerative colitis	0.000124	0.000311	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000124	0.00031	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000124	0.00031	CcSEcCtD
Everolimus—Pain—Hydrocortisone—ulcerative colitis	0.000123	0.000309	CcSEcCtD
Everolimus—Oedema—Betamethasone—ulcerative colitis	0.000123	0.000309	CcSEcCtD
Everolimus—Oedema—Dexamethasone—ulcerative colitis	0.000123	0.000309	CcSEcCtD
Everolimus—MTOR—Signaling by SCF-KIT—IL6—ulcerative colitis	0.000123	0.000686	CbGpPWpGaD
Everolimus—Insomnia—Triamcinolone—ulcerative colitis	0.000123	0.000308	CcSEcCtD
Everolimus—Insomnia—Methylprednisolone—ulcerative colitis	0.000123	0.000307	CcSEcCtD
Everolimus—MTOR—Immune System—FCGR2A—ulcerative colitis	0.000123	0.000683	CbGpPWpGaD
Everolimus—Infection—Betamethasone—ulcerative colitis	0.000123	0.000307	CcSEcCtD
Everolimus—Infection—Dexamethasone—ulcerative colitis	0.000123	0.000307	CcSEcCtD
Everolimus—Ill-defined disorder—Prednisone—ulcerative colitis	0.000122	0.000306	CcSEcCtD
Everolimus—Paraesthesia—Triamcinolone—ulcerative colitis	0.000122	0.000306	CcSEcCtD
Everolimus—Feeling abnormal—Prednisolone—ulcerative colitis	0.000122	0.000305	CcSEcCtD
Everolimus—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000122	0.000305	CcSEcCtD
Everolimus—Anaemia—Prednisone—ulcerative colitis	0.000122	0.000305	CcSEcCtD
Everolimus—Shock—Dexamethasone—ulcerative colitis	0.000121	0.000304	CcSEcCtD
Everolimus—Shock—Betamethasone—ulcerative colitis	0.000121	0.000304	CcSEcCtD
Everolimus—Dyspnoea—Triamcinolone—ulcerative colitis	0.000121	0.000304	CcSEcCtD
Everolimus—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000121	0.000303	CcSEcCtD
Everolimus—Nervous system disorder—Betamethasone—ulcerative colitis	0.000121	0.000303	CcSEcCtD
Everolimus—Agitation—Prednisone—ulcerative colitis	0.000121	0.000303	CcSEcCtD
Everolimus—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000121	0.000303	CcSEcCtD
Everolimus—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000121	0.000303	CcSEcCtD
Everolimus—Nausea—Mesalazine—ulcerative colitis	0.000121	0.000302	CcSEcCtD
Everolimus—Tachycardia—Betamethasone—ulcerative colitis	0.00012	0.000302	CcSEcCtD
Everolimus—Tachycardia—Dexamethasone—ulcerative colitis	0.00012	0.000302	CcSEcCtD
Everolimus—Angioedema—Prednisone—ulcerative colitis	0.00012	0.000301	CcSEcCtD
Everolimus—Dyspepsia—Triamcinolone—ulcerative colitis	0.00012	0.0003	CcSEcCtD
Everolimus—FKBP1A—Disease—ADCY5—ulcerative colitis	0.000119	0.000665	CbGpPWpGaD
Everolimus—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000119	0.000299	CcSEcCtD
Everolimus—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000119	0.000299	CcSEcCtD
Everolimus—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000119	0.000299	CcSEcCtD
Everolimus—FKBP1A—Signaling Pathways—GHRL—ulcerative colitis	0.000119	0.000663	CbGpPWpGaD
Everolimus—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000119	0.000298	CcSEcCtD
Everolimus—MTOR—Cellular responses to stress—NFKB1—ulcerative colitis	0.000119	0.000662	CbGpPWpGaD
Everolimus—Malaise—Prednisone—ulcerative colitis	0.000119	0.000298	CcSEcCtD
Everolimus—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000118	0.000296	CcSEcCtD
Everolimus—Syncope—Prednisone—ulcerative colitis	0.000118	0.000296	CcSEcCtD
Everolimus—MTOR—Downstream signaling of activated FGFR—IL6—ulcerative colitis	0.000118	0.000657	CbGpPWpGaD
Everolimus—Anorexia—Dexamethasone—ulcerative colitis	0.000118	0.000295	CcSEcCtD
Everolimus—Anorexia—Betamethasone—ulcerative colitis	0.000118	0.000295	CcSEcCtD
Everolimus—MTOR—Immune System—PTPN2—ulcerative colitis	0.000117	0.000654	CbGpPWpGaD
Everolimus—Fatigue—Triamcinolone—ulcerative colitis	0.000117	0.000294	CcSEcCtD
Everolimus—Fatigue—Methylprednisolone—ulcerative colitis	0.000117	0.000293	CcSEcCtD
Everolimus—Pain—Triamcinolone—ulcerative colitis	0.000116	0.000291	CcSEcCtD
Everolimus—MTOR—Signaling by ERBB4—IL6—ulcerative colitis	0.000116	0.000646	CbGpPWpGaD
Everolimus—Loss of consciousness—Prednisone—ulcerative colitis	0.000116	0.00029	CcSEcCtD
Everolimus—FKBP1A—Signaling Pathways—CALM3—ulcerative colitis	0.000115	0.000642	CbGpPWpGaD
Everolimus—Hypotension—Betamethasone—ulcerative colitis	0.000115	0.000289	CcSEcCtD
Everolimus—Hypotension—Dexamethasone—ulcerative colitis	0.000115	0.000289	CcSEcCtD
Everolimus—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000114	0.000286	CcSEcCtD
Everolimus—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000114	0.000286	CcSEcCtD
Everolimus—Convulsion—Prednisone—ulcerative colitis	0.000114	0.000286	CcSEcCtD
Everolimus—Hypertension—Prednisone—ulcerative colitis	0.000114	0.000285	CcSEcCtD
Everolimus—FKBP1A—Signaling Pathways—RIPK2—ulcerative colitis	0.000114	0.000632	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CXCR1—ulcerative colitis	0.000113	0.000629	CbGpPWpGaD
Everolimus—MTOR—Disease—MAML2—ulcerative colitis	0.000112	0.000626	CbGpPWpGaD
Everolimus—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000112	0.000282	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000112	0.000282	CcSEcCtD
Everolimus—Myalgia—Prednisone—ulcerative colitis	0.000112	0.000281	CcSEcCtD
Everolimus—Arthralgia—Prednisone—ulcerative colitis	0.000112	0.000281	CcSEcCtD
Everolimus—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000112	0.000281	CcSEcCtD
Everolimus—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000112	0.00028	CcSEcCtD
Everolimus—Anxiety—Prednisone—ulcerative colitis	0.000112	0.00028	CcSEcCtD
Everolimus—Insomnia—Dexamethasone—ulcerative colitis	0.000112	0.00028	CcSEcCtD
Everolimus—Insomnia—Betamethasone—ulcerative colitis	0.000112	0.00028	CcSEcCtD
Everolimus—MTOR—Signaling by NGF—NFKB1—ulcerative colitis	0.000112	0.000621	CbGpPWpGaD
Everolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000111	0.000279	CcSEcCtD
Everolimus—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000111	0.000278	CcSEcCtD
Everolimus—MTOR—Downstream signal transduction—IL6—ulcerative colitis	0.000111	0.000617	CbGpPWpGaD
Everolimus—Paraesthesia—Betamethasone—ulcerative colitis	0.000111	0.000278	CcSEcCtD
Everolimus—Paraesthesia—Dexamethasone—ulcerative colitis	0.000111	0.000278	CcSEcCtD
Everolimus—Discomfort—Prednisone—ulcerative colitis	0.000111	0.000277	CcSEcCtD
Everolimus—MTOR—Signaling by FGFR—IL6—ulcerative colitis	0.00011	0.000614	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—IL6—ulcerative colitis	0.00011	0.000611	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—CRP—ulcerative colitis	0.000109	0.000609	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—IL6—ulcerative colitis	0.000109	0.000608	CbGpPWpGaD
Everolimus—Hypersensitivity—Prednisolone—ulcerative colitis	0.000109	0.000273	CcSEcCtD
Everolimus—Dyspepsia—Dexamethasone—ulcerative colitis	0.000109	0.000272	CcSEcCtD
Everolimus—Dyspepsia—Betamethasone—ulcerative colitis	0.000109	0.000272	CcSEcCtD
Everolimus—Body temperature increased—Triamcinolone—ulcerative colitis	0.000107	0.000269	CcSEcCtD
Everolimus—Oedema—Prednisone—ulcerative colitis	0.000107	0.000269	CcSEcCtD
Everolimus—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000107	0.000269	CcSEcCtD
Everolimus—Decreased appetite—Dexamethasone—ulcerative colitis	0.000107	0.000269	CcSEcCtD
Everolimus—Decreased appetite—Betamethasone—ulcerative colitis	0.000107	0.000269	CcSEcCtD
Everolimus—MTOR—Cellular responses to stress—STAT3—ulcerative colitis	0.000107	0.000595	CbGpPWpGaD
Everolimus—Infection—Prednisone—ulcerative colitis	0.000107	0.000267	CcSEcCtD
Everolimus—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000106	0.000267	CcSEcCtD
Everolimus—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000106	0.000267	CcSEcCtD
Everolimus—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000106	0.000267	CcSEcCtD
Everolimus—Fatigue—Betamethasone—ulcerative colitis	0.000106	0.000267	CcSEcCtD
Everolimus—Fatigue—Dexamethasone—ulcerative colitis	0.000106	0.000267	CcSEcCtD
Everolimus—Shock—Prednisone—ulcerative colitis	0.000106	0.000265	CcSEcCtD
Everolimus—Pain—Betamethasone—ulcerative colitis	0.000105	0.000264	CcSEcCtD
Everolimus—Pain—Dexamethasone—ulcerative colitis	0.000105	0.000264	CcSEcCtD
Everolimus—Nervous system disorder—Prednisone—ulcerative colitis	0.000105	0.000264	CcSEcCtD
Everolimus—Tachycardia—Prednisone—ulcerative colitis	0.000105	0.000263	CcSEcCtD
Everolimus—MTOR—Innate Immune System—TLR4—ulcerative colitis	0.000105	0.000584	CbGpPWpGaD
Everolimus—Skin disorder—Prednisone—ulcerative colitis	0.000104	0.000262	CcSEcCtD
Everolimus—Hyperhidrosis—Prednisone—ulcerative colitis	0.000104	0.00026	CcSEcCtD
Everolimus—Asthenia—Hydrocortisone—ulcerative colitis	0.000104	0.00026	CcSEcCtD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—ulcerative colitis	0.000103	0.000572	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—IL6—ulcerative colitis	0.000103	0.000572	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—IL6—ulcerative colitis	0.000103	0.000572	CbGpPWpGaD
Everolimus—Anorexia—Prednisone—ulcerative colitis	0.000102	0.000257	CcSEcCtD
Everolimus—Pruritus—Hydrocortisone—ulcerative colitis	0.000102	0.000256	CcSEcCtD
Everolimus—MTOR—Signaling by EGFR—IL6—ulcerative colitis	0.000102	0.000567	CbGpPWpGaD
Everolimus—Feeling abnormal—Betamethasone—ulcerative colitis	0.000102	0.000255	CcSEcCtD
Everolimus—Feeling abnormal—Dexamethasone—ulcerative colitis	0.000102	0.000255	CcSEcCtD
Everolimus—MTOR—Signaling by EGFR in Cancer—IL6—ulcerative colitis	0.000101	0.000562	CbGpPWpGaD
Everolimus—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000101	0.000253	CcSEcCtD
Everolimus—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000101	0.000253	CcSEcCtD
Everolimus—MTOR—Adaptive Immune System—HLA-DRB1—ulcerative colitis	0.000101	0.00056	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—IL6—ulcerative colitis	0.0001	0.00056	CbGpPWpGaD
Everolimus—MTOR—Immune System—CALM3—ulcerative colitis	0.0001	0.000559	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—STAT3—ulcerative colitis	0.0001	0.000558	CbGpPWpGaD
Everolimus—Hypersensitivity—Triamcinolone—ulcerative colitis	0.0001	0.000251	CcSEcCtD
Everolimus—Hypersensitivity—Methylprednisolone—ulcerative colitis	9.99e-05	0.00025	CcSEcCtD
Everolimus—MTOR—Signaling Pathways—CCL20—ulcerative colitis	9.91e-05	0.000552	CbGpPWpGaD
Everolimus—MTOR—Immune System—RIPK2—ulcerative colitis	9.88e-05	0.00055	CbGpPWpGaD
Everolimus—Diarrhoea—Hydrocortisone—ulcerative colitis	9.88e-05	0.000248	CcSEcCtD
Everolimus—FKBP1A—Signaling Pathways—ADRB2—ulcerative colitis	9.85e-05	0.000549	CbGpPWpGaD
Everolimus—Musculoskeletal discomfort—Prednisone—ulcerative colitis	9.79e-05	0.000245	CcSEcCtD
Everolimus—Dizziness—Prednisolone—ulcerative colitis	9.77e-05	0.000245	CcSEcCtD
Everolimus—Asthenia—Triamcinolone—ulcerative colitis	9.75e-05	0.000244	CcSEcCtD
Everolimus—Abdominal pain—Betamethasone—ulcerative colitis	9.75e-05	0.000244	CcSEcCtD
Everolimus—Body temperature increased—Betamethasone—ulcerative colitis	9.75e-05	0.000244	CcSEcCtD
Everolimus—Body temperature increased—Dexamethasone—ulcerative colitis	9.75e-05	0.000244	CcSEcCtD
Everolimus—Abdominal pain—Dexamethasone—ulcerative colitis	9.75e-05	0.000244	CcSEcCtD
Everolimus—MTOR—Immune System—CTLA4—ulcerative colitis	9.74e-05	0.000542	CbGpPWpGaD
Everolimus—Asthenia—Methylprednisolone—ulcerative colitis	9.73e-05	0.000244	CcSEcCtD
Everolimus—Insomnia—Prednisone—ulcerative colitis	9.71e-05	0.000244	CcSEcCtD
Everolimus—MTOR—Adaptive Immune System—ICAM1—ulcerative colitis	9.65e-05	0.000537	CbGpPWpGaD
Everolimus—Paraesthesia—Prednisone—ulcerative colitis	9.64e-05	0.000242	CcSEcCtD
Everolimus—Pruritus—Triamcinolone—ulcerative colitis	9.62e-05	0.000241	CcSEcCtD
Everolimus—Pruritus—Methylprednisolone—ulcerative colitis	9.6e-05	0.000241	CcSEcCtD
Everolimus—Dizziness—Hydrocortisone—ulcerative colitis	9.55e-05	0.000239	CcSEcCtD
Everolimus—Dyspepsia—Prednisone—ulcerative colitis	9.45e-05	0.000237	CcSEcCtD
Everolimus—Decreased appetite—Prednisone—ulcerative colitis	9.34e-05	0.000234	CcSEcCtD
Everolimus—Rash—Prednisolone—ulcerative colitis	9.32e-05	0.000234	CcSEcCtD
Everolimus—MTOR—Signaling Pathways—GNA12—ulcerative colitis	9.32e-05	0.000519	CbGpPWpGaD
Everolimus—Dermatitis—Prednisolone—ulcerative colitis	9.31e-05	0.000233	CcSEcCtD
Everolimus—MTOR—Immune System—CD79A—ulcerative colitis	9.29e-05	0.000517	CbGpPWpGaD
Everolimus—Diarrhoea—Methylprednisolone—ulcerative colitis	9.28e-05	0.000233	CcSEcCtD
Everolimus—Fatigue—Prednisone—ulcerative colitis	9.26e-05	0.000232	CcSEcCtD
Everolimus—Headache—Prednisolone—ulcerative colitis	9.26e-05	0.000232	CcSEcCtD
Everolimus—MTOR—Disease—CALM3—ulcerative colitis	9.26e-05	0.000516	CbGpPWpGaD
Everolimus—Constipation—Prednisone—ulcerative colitis	9.19e-05	0.00023	CcSEcCtD
Everolimus—Vomiting—Hydrocortisone—ulcerative colitis	9.18e-05	0.00023	CcSEcCtD
Everolimus—Rash—Hydrocortisone—ulcerative colitis	9.1e-05	0.000228	CcSEcCtD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—ulcerative colitis	9.1e-05	0.000507	CbGpPWpGaD
Everolimus—Dermatitis—Hydrocortisone—ulcerative colitis	9.09e-05	0.000228	CcSEcCtD
Everolimus—Headache—Hydrocortisone—ulcerative colitis	9.04e-05	0.000227	CcSEcCtD
Everolimus—Dizziness—Triamcinolone—ulcerative colitis	8.99e-05	0.000225	CcSEcCtD
Everolimus—Dizziness—Methylprednisolone—ulcerative colitis	8.97e-05	0.000225	CcSEcCtD
Everolimus—MTOR—Immune System—NOD2—ulcerative colitis	8.96e-05	0.000499	CbGpPWpGaD
Everolimus—MTOR—Immune System—CD14—ulcerative colitis	8.9e-05	0.000496	CbGpPWpGaD
Everolimus—Feeling abnormal—Prednisone—ulcerative colitis	8.85e-05	0.000222	CcSEcCtD
Everolimus—Asthenia—Betamethasone—ulcerative colitis	8.85e-05	0.000222	CcSEcCtD
Everolimus—Asthenia—Dexamethasone—ulcerative colitis	8.85e-05	0.000222	CcSEcCtD
Everolimus—MTOR—Signaling Pathways—CXCR2—ulcerative colitis	8.83e-05	0.000492	CbGpPWpGaD
Everolimus—Gastrointestinal pain—Prednisone—ulcerative colitis	8.78e-05	0.00022	CcSEcCtD
Everolimus—Nausea—Prednisolone—ulcerative colitis	8.78e-05	0.00022	CcSEcCtD
Everolimus—Pruritus—Dexamethasone—ulcerative colitis	8.73e-05	0.000219	CcSEcCtD
Everolimus—Pruritus—Betamethasone—ulcerative colitis	8.73e-05	0.000219	CcSEcCtD
Everolimus—Vomiting—Triamcinolone—ulcerative colitis	8.64e-05	0.000217	CcSEcCtD
Everolimus—Vomiting—Methylprednisolone—ulcerative colitis	8.62e-05	0.000216	CcSEcCtD
Everolimus—MTOR—Immune System—VCAM1—ulcerative colitis	8.59e-05	0.000479	CbGpPWpGaD
Everolimus—Nausea—Hydrocortisone—ulcerative colitis	8.57e-05	0.000215	CcSEcCtD
Everolimus—MTOR—Immune System—HLA-DQA1—ulcerative colitis	8.57e-05	0.000477	CbGpPWpGaD
Everolimus—Rash—Triamcinolone—ulcerative colitis	8.57e-05	0.000215	CcSEcCtD
Everolimus—Dermatitis—Triamcinolone—ulcerative colitis	8.56e-05	0.000215	CcSEcCtD
Everolimus—Rash—Methylprednisolone—ulcerative colitis	8.55e-05	0.000214	CcSEcCtD
Everolimus—Dermatitis—Methylprednisolone—ulcerative colitis	8.54e-05	0.000214	CcSEcCtD
Everolimus—MTOR—Adaptive Immune System—CDH1—ulcerative colitis	8.53e-05	0.000475	CbGpPWpGaD
Everolimus—Headache—Triamcinolone—ulcerative colitis	8.52e-05	0.000213	CcSEcCtD
Everolimus—Headache—Methylprednisolone—ulcerative colitis	8.5e-05	0.000213	CcSEcCtD
Everolimus—Abdominal pain—Prednisone—ulcerative colitis	8.49e-05	0.000213	CcSEcCtD
Everolimus—Body temperature increased—Prednisone—ulcerative colitis	8.49e-05	0.000213	CcSEcCtD
Everolimus—Diarrhoea—Betamethasone—ulcerative colitis	8.44e-05	0.000212	CcSEcCtD
Everolimus—Diarrhoea—Dexamethasone—ulcerative colitis	8.44e-05	0.000212	CcSEcCtD
Everolimus—FKBP1A—Signaling Pathways—ADCY5—ulcerative colitis	8.36e-05	0.000466	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CCR6—ulcerative colitis	8.31e-05	0.000463	CbGpPWpGaD
Everolimus—Dizziness—Betamethasone—ulcerative colitis	8.16e-05	0.000204	CcSEcCtD
Everolimus—Dizziness—Dexamethasone—ulcerative colitis	8.16e-05	0.000204	CcSEcCtD
Everolimus—MTOR—Cellular responses to stress—TP53—ulcerative colitis	8.15e-05	0.000454	CbGpPWpGaD
Everolimus—Nausea—Triamcinolone—ulcerative colitis	8.07e-05	0.000202	CcSEcCtD
Everolimus—Nausea—Methylprednisolone—ulcerative colitis	8.06e-05	0.000202	CcSEcCtD
Everolimus—Hypersensitivity—Prednisone—ulcerative colitis	7.91e-05	0.000198	CcSEcCtD
Everolimus—MTOR—Signaling Pathways—MAML2—ulcerative colitis	7.87e-05	0.000439	CbGpPWpGaD
Everolimus—Vomiting—Betamethasone—ulcerative colitis	7.84e-05	0.000197	CcSEcCtD
Everolimus—Vomiting—Dexamethasone—ulcerative colitis	7.84e-05	0.000197	CcSEcCtD
Everolimus—MTOR—Innate Immune System—JAK2—ulcerative colitis	7.79e-05	0.000434	CbGpPWpGaD
Everolimus—Rash—Dexamethasone—ulcerative colitis	7.78e-05	0.000195	CcSEcCtD
Everolimus—Rash—Betamethasone—ulcerative colitis	7.78e-05	0.000195	CcSEcCtD
Everolimus—Dermatitis—Dexamethasone—ulcerative colitis	7.77e-05	0.000195	CcSEcCtD
Everolimus—Dermatitis—Betamethasone—ulcerative colitis	7.77e-05	0.000195	CcSEcCtD
Everolimus—Headache—Dexamethasone—ulcerative colitis	7.73e-05	0.000194	CcSEcCtD
Everolimus—Headache—Betamethasone—ulcerative colitis	7.73e-05	0.000194	CcSEcCtD
Everolimus—Asthenia—Prednisone—ulcerative colitis	7.71e-05	0.000193	CcSEcCtD
Everolimus—Pruritus—Prednisone—ulcerative colitis	7.6e-05	0.00019	CcSEcCtD
Everolimus—MTOR—Innate Immune System—RELA—ulcerative colitis	7.54e-05	0.00042	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—IL6—ulcerative colitis	7.46e-05	0.000416	CbGpPWpGaD
Everolimus—FKBP1A—Disease—JAK2—ulcerative colitis	7.45e-05	0.000415	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—CD4—ulcerative colitis	7.38e-05	0.000411	CbGpPWpGaD
Everolimus—Diarrhoea—Prednisone—ulcerative colitis	7.35e-05	0.000184	CcSEcCtD
Everolimus—Nausea—Dexamethasone—ulcerative colitis	7.33e-05	0.000184	CcSEcCtD
Everolimus—Nausea—Betamethasone—ulcerative colitis	7.33e-05	0.000184	CcSEcCtD
Everolimus—MTOR—Signaling Pathways—PTGER4—ulcerative colitis	7.31e-05	0.000407	CbGpPWpGaD
Everolimus—MTOR—Immune System—ADCY5—ulcerative colitis	7.28e-05	0.000405	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—RELA—ulcerative colitis	7.24e-05	0.000403	CbGpPWpGaD
Everolimus—Dizziness—Prednisone—ulcerative colitis	7.1e-05	0.000178	CcSEcCtD
Everolimus—MTOR—Adaptive Immune System—CD4—ulcerative colitis	7.09e-05	0.000395	CbGpPWpGaD
Everolimus—FKBP1A—Disease—CD4—ulcerative colitis	7.06e-05	0.000393	CbGpPWpGaD
Everolimus—FKBP1A—Disease—PTGS2—ulcerative colitis	7.01e-05	0.00039	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—IL6—ulcerative colitis	7e-05	0.00039	CbGpPWpGaD
Everolimus—Vomiting—Prednisone—ulcerative colitis	6.83e-05	0.000171	CcSEcCtD
Everolimus—Rash—Prednisone—ulcerative colitis	6.77e-05	0.00017	CcSEcCtD
Everolimus—Dermatitis—Prednisone—ulcerative colitis	6.77e-05	0.00017	CcSEcCtD
Everolimus—Headache—Prednisone—ulcerative colitis	6.73e-05	0.000169	CcSEcCtD
Everolimus—MTOR—Disease—ADCY5—ulcerative colitis	6.72e-05	0.000374	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—GHRL—ulcerative colitis	6.69e-05	0.000373	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CALM3—ulcerative colitis	6.48e-05	0.000361	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—RIPK2—ulcerative colitis	6.39e-05	0.000356	CbGpPWpGaD
Everolimus—Nausea—Prednisone—ulcerative colitis	6.38e-05	0.00016	CcSEcCtD
Everolimus—MTOR—Immune System—CRP—ulcerative colitis	6.37e-05	0.000355	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—NFKB1—ulcerative colitis	6.36e-05	0.000354	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—NFKB1—ulcerative colitis	6.11e-05	0.00034	CbGpPWpGaD
Everolimus—MTOR—Immune System—TLR4—ulcerative colitis	6.1e-05	0.00034	CbGpPWpGaD
Everolimus—MTOR—Immune System—HLA-DRB1—ulcerative colitis	6.1e-05	0.00034	CbGpPWpGaD
Everolimus—MTOR—Immune System—ICAM1—ulcerative colitis	5.85e-05	0.000326	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—ADRB2—ulcerative colitis	5.54e-05	0.000309	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CHP1—ulcerative colitis	5.47e-05	0.000305	CbGpPWpGaD
Everolimus—FKBP1A—Disease—STAT3—ulcerative colitis	5.47e-05	0.000304	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—JAK2—ulcerative colitis	5.21e-05	0.00029	CbGpPWpGaD
Everolimus—MTOR—Immune System—CDH1—ulcerative colitis	5.17e-05	0.000288	CbGpPWpGaD
Everolimus—FKBP1A—Disease—TGFB1—ulcerative colitis	5.07e-05	0.000282	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—RELA—ulcerative colitis	5.05e-05	0.000281	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CXCL8—ulcerative colitis	4.76e-05	0.000265	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—DLD—ulcerative colitis	4.73e-05	0.000263	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—ADCY5—ulcerative colitis	4.7e-05	0.000262	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—IL2—ulcerative colitis	4.55e-05	0.000253	CbGpPWpGaD
Everolimus—MTOR—Immune System—JAK2—ulcerative colitis	4.54e-05	0.000253	CbGpPWpGaD
Everolimus—MTOR—Immune System—IFNG—ulcerative colitis	4.45e-05	0.000248	CbGpPWpGaD
Everolimus—MTOR—Immune System—RELA—ulcerative colitis	4.39e-05	0.000245	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—MMP9—ulcerative colitis	4.3e-05	0.00024	CbGpPWpGaD
Everolimus—MTOR—Immune System—CD4—ulcerative colitis	4.3e-05	0.000239	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—NFKB1—ulcerative colitis	4.26e-05	0.000237	CbGpPWpGaD
Everolimus—MTOR—Disease—JAK2—ulcerative colitis	4.19e-05	0.000233	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—IL6—ulcerative colitis	3.99e-05	0.000222	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL1B—ulcerative colitis	3.97e-05	0.000221	CbGpPWpGaD
Everolimus—MTOR—Disease—CD4—ulcerative colitis	3.97e-05	0.000221	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL2—ulcerative colitis	3.96e-05	0.00022	CbGpPWpGaD
Everolimus—MTOR—Disease—PTGS2—ulcerative colitis	3.94e-05	0.000219	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—STAT3—ulcerative colitis	3.83e-05	0.000213	CbGpPWpGaD
Everolimus—FKBP1A—Disease—IL6—ulcerative colitis	3.82e-05	0.000213	CbGpPWpGaD
Everolimus—MTOR—Immune System—NFKB1—ulcerative colitis	3.7e-05	0.000206	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—TGFB1—ulcerative colitis	3.55e-05	0.000198	CbGpPWpGaD
Everolimus—MTOR—Immune System—STAT3—ulcerative colitis	3.33e-05	0.000185	CbGpPWpGaD
Everolimus—MTOR—Disease—STAT3—ulcerative colitis	3.07e-05	0.000171	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—JAK2—ulcerative colitis	2.93e-05	0.000163	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—TP53—ulcerative colitis	2.92e-05	0.000163	CbGpPWpGaD
Everolimus—MTOR—Disease—TGFB1—ulcerative colitis	2.85e-05	0.000159	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—RELA—ulcerative colitis	2.84e-05	0.000158	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CXCL8—ulcerative colitis	2.68e-05	0.000149	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—IL6—ulcerative colitis	2.67e-05	0.000149	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IL2—ulcerative colitis	2.56e-05	0.000142	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MMP9—ulcerative colitis	2.42e-05	0.000135	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NFKB1—ulcerative colitis	2.4e-05	0.000133	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL6—ulcerative colitis	2.33e-05	0.00013	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PTGS1—ulcerative colitis	2.28e-05	0.000127	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—STAT3—ulcerative colitis	2.15e-05	0.00012	CbGpPWpGaD
Everolimus—MTOR—Disease—IL6—ulcerative colitis	2.15e-05	0.00012	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CALM3—ulcerative colitis	2.06e-05	0.000115	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TGFB1—ulcerative colitis	2e-05	0.000111	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TP53—ulcerative colitis	1.64e-05	9.15e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ABCB1—ulcerative colitis	1.6e-05	8.91e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IL6—ulcerative colitis	1.5e-05	8.37e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ADCY5—ulcerative colitis	1.49e-05	8.31e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PPARG—ulcerative colitis	1.11e-05	6.2e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ALB—ulcerative colitis	1e-05	5.57e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PTGS2—ulcerative colitis	8.75e-06	4.88e-05	CbGpPWpGaD
